Journal articleJ Control Release2023
Nanoparticles of VAV1 siRNA combined with LL37 peptide for the treatment of pancreatic cancer.
- Journal
- J Control Release
- Published
- 9 February 2023
- Citations
- 13
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Pancreatic ductal adenocarcinoma (PDAC) is among the leading causes of cancer-related death, and it is highly resistant to therapy owing to its unique extracellular matrix. VAV1 protein, overexpressed in several cancer diseases including pancreatic cancer (PC), increases tumor proliferation and enhances metastases formation, which are associated with decreased survival. … Excerpt only: this text is the publisher’s. Read it in full at the source.